| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/1997 | CA2183052A1 Use of acyl-substituted aminopyrans |
| 02/15/1997 | CA2183049A1 Derivatives of 12, 13-epoxy-tylosin and processes of manufacture thereof |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/15/1997 | CA2156013A1 Modulation of cellular activity |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005279A1 Methods of predicting the outcome of infection |
| 02/13/1997 | WO1997005270A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | WO1997005269A1 Process for the preparation of lovastatin |
| 02/13/1997 | WO1997005267A2 Mucosal delivery of polynucleotides |
| 02/13/1997 | WO1997005254A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 02/13/1997 | WO1997005253A2 Transketolase-related protein |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005244A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005195A1 Method of detecting lung disease |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997005168A1 The h-y antigen |
| 02/13/1997 | WO1997005167A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | WO1997005164A1 Papillomavirus polyprotein constructs |
| 02/13/1997 | WO1997005163A1 Cyclic peptide anti-fungal agents |
| 02/13/1997 | WO1997005155A1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use |
| 02/13/1997 | WO1997005154A1 Improved therapeutic agents |
| 02/13/1997 | WO1997005142A1 Process for the preparation of potassium clavulanate |
| 02/13/1997 | WO1997005139A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/13/1997 | WO1997005137A1 Heterocyclic compounds, their preparation and use |
| 02/13/1997 | WO1997005136A1 Ipratropium bromide enantiomer with a prolonged duration of action |
| 02/13/1997 | WO1997005134A1 Heterocyclic compounds for treating myocardial ischaemia |
| 02/13/1997 | WO1997005131A1 New carboxamides with antifungal activity |
| 02/13/1997 | WO1997005130A1 New pyrimidone derivatives with antifungal activity |
| 02/13/1997 | WO1997005129A1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
| 02/13/1997 | WO1997005127A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | WO1997005113A1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases |
| 02/13/1997 | WO1997005111A1 N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 02/13/1997 | WO1997005109A1 Heterocyclic compounds, their preparation and use |
| 02/13/1997 | WO1997005105A1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 02/13/1997 | WO1997005102A1 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 02/13/1997 | WO1997004808A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| 02/13/1997 | WO1997004807A1 Methods for treatment of allergic asthma |
| 02/13/1997 | WO1997004800A1 Treatment of nocturnal polyuria using an ace inhibitor in combination with a diuretic |
| 02/13/1997 | WO1997004796A1 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 02/13/1997 | WO1997004792A1 Bowman-birk inhibitor compositions for treatment of imflammatory disease |
| 02/13/1997 | WO1997004791A1 Antiviral agent and process for preparing the same |
| 02/13/1997 | WO1997004789A1 Tablets containing anion exchange resin |
| 02/13/1997 | WO1997004788A2 Use of calendula glycosides for the treatment of psoriasis |
| 02/13/1997 | WO1997004787A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | WO1997004785A1 Use of phenol substituted diphosphonates as antineoplastic agents |
| 02/13/1997 | WO1997004784A1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 02/13/1997 | WO1997004783A2 Bis-1-oxaquinolizidine alkaloids from a marine sponge with antitumor activity |
| 02/13/1997 | WO1997004781A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004780A2 Pain-alleviating drug composition and method for alleviating pain |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004778A1 Pyridine compounds, intermediates, processes, compositions, and methods |
| 02/13/1997 | WO1997004777A1 Use off unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |
| 02/13/1997 | WO1997004776A1 Radioprotectors |
| 02/13/1997 | WO1997004775A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004774A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004773A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004772A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004771A1 Benzimidazole compounds |
| 02/13/1997 | WO1997004769A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004767A1 Hydroxyl radical scavenger |
| 02/13/1997 | WO1997004766A1 Retinoid suppression of ventricular muscle cell hypertrophy |
| 02/13/1997 | WO1997004765A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS |
| 02/13/1997 | WO1997004764A1 Topical phenylephrine preparation |
| 02/13/1997 | WO1997004763A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | WO1997004762A1 Use of adamantane derivatives for treating diseases of the inner ear |
| 02/13/1997 | WO1997004761A1 Methods and compositions for treating cell proliferative disorders |
| 02/13/1997 | WO1997004760A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | WO1997004759A1 Transdermal patch containing aspirin |
| 02/13/1997 | WO1997004758A1 Pharmaceutical preparation for percutaneous absorbtion |
| 02/13/1997 | WO1997004757A1 Transdermal nitrate formulation |
| 02/13/1997 | WO1997004753A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 02/13/1997 | WO1997004752A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 02/13/1997 | WO1997004750A2 Process for preparing solid dosage forms of very low-dose drugs |
| 02/13/1997 | WO1997004749A1 Method for preparing dry pharmaceutical forms, and resulting pharmaceutical compositions |
| 02/13/1997 | WO1997004746A1 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers |
| 02/13/1997 | WO1997004728A1 Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
| 02/13/1997 | WO1997004668A2 Two-stage preparation |
| 02/13/1997 | WO1997004657A1 Novel embolizing compositions |
| 02/13/1997 | WO1997002003A3 Compositions |
| 02/13/1997 | WO1996040627A3 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 02/13/1997 | WO1996040128A3 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 02/13/1997 | WO1996040086A3 Compositions and methods for topical administration of pharmaceutically active agents |
| 02/13/1997 | WO1996040058A3 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
| 02/13/1997 | WO1996036339A3 Use of dihydrotestosterone compounds for treating male sexual dysfunction |
| 02/13/1997 | WO1996032109A3 Levobupivacaine and its use as an anaesthetic in pregnant women |
| 02/13/1997 | WO1996029076A3 Treatment of inflammatory bowel disorders with cotinine |
| 02/13/1997 | WO1996002240A3 Use of inhibitors of human s-cd23 |
| 02/13/1997 | DE19529612A1 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate Sulfonyl or sulfinyl derivatives benzoylguanidine |
| 02/13/1997 | DE19529604A1 Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung Endoparasiticidal compositions based on didepsipeptides new didepsipeptides and to a process for their preparation |
| 02/13/1997 | DE19529102A1 Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen Use of PDE inhibitors in the treatment of urinary bladder diseases |
| 02/13/1997 | CA2228691A1 Heterocyclic compounds for treating myocardial ischaemia |
| 02/13/1997 | CA2228378A1 Cytidine deaminase cdna as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228296A1 Endothelin receptor antagonists |
| 02/13/1997 | CA2228293A1 Endothelin receptor antagonists |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2228212A1 Use of phenol substituted diphosphonates as antineoplastic agents |
| 02/13/1997 | CA2228178A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |